Trials / Completed
CompletedNCT01195168
Cardiovascular Risk Markers in Polycystic Ovary Syndrome (PCOS)
Assessment of Cardiovascular Risk in PCOS-a Cross Sectional Study of Women With PCOS Compared With Controls Matched for Age, Body Mass Index and, or Insulin Resistance
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 201 (actual)
- Sponsor
- The Adelaide and Meath Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
Women with polycystic ovary syndrome (PCOS) are more often overweight or obese and are more insulin resistant than women without the condition and may be at greater risk of developing cardiovascular disease. It is not know whether it is the overweight and insulin resistant component of PCOS, or PCOS per se which leads to the greater cardiovascular disease risk. The aim of this study was to examine cardiovascular risk markers in women with PCOS versus a control population matched for body mass index (BMI), and or, insulin resistance
Conditions
Timeline
- Start date
- 2006-11-01
- Primary completion
- 2008-07-01
- Completion
- 2008-07-01
- First posted
- 2010-09-06
- Last updated
- 2010-09-06
Locations
2 sites across 1 country: Ireland
Source: ClinicalTrials.gov record NCT01195168. Inclusion in this directory is not an endorsement.